These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1257 related articles for article (PubMed ID: 8904913)

  • 21. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
    Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
    Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
    Ruiz A; Puig S; Malvehy J; Lázaro C; Lynch M; Gimenez-Arnau AM; Puig L; Sánchez-Conejo J; Estivill X; Castel T
    J Med Genet; 1999 Jun; 36(6):490-3. PubMed ID: 10874641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients.
    Terleth C; van Laar T; Schouten R; van Steeg H; Hodemaekers H; Wormhoudt T; Cornelissen-Steijger PD; Abrahams PJ; van der Eb AJ
    Cancer Res; 1997 Oct; 57(19):4384-92. PubMed ID: 9331102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A clinical and genetic study on 11 cases of xeroderma pigmentosum].
    Wang DB
    Zhonghua Yi Xue Za Zhi; 1983 Jan; 63(1):9-13. PubMed ID: 6406014
    [No Abstract]   [Full Text] [Related]  

  • 26. [Melanoma in xeroderma pigmentosum: 12 cases].
    Fazaa B; Zghal M; Bailly C; Zeglaoui F; Goucha S; Mokhtar I; Kharfi M; Ezzine N; Kamoun MR
    Ann Dermatol Venereol; 2001 Apr; 128(4):503-6. PubMed ID: 11395647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial melanoma associated with dominant ultraviolet radiation sensitivity.
    Ramsay RG; Chen P; Imray FP; Kidson C; Lavin MF; Hockey A
    Cancer Res; 1982 Jul; 42(7):2909-12. PubMed ID: 7083179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
    Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
    Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
    Daya-Grosjean L; Sarasin A
    Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.
    Howell WM; Turner SJ; Bateman AC; Theaker JM
    Genes Immun; 2001 Feb; 2(1):25-31. PubMed ID: 11294564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal susceptibility to UV induced cutaneous malignant melanoma in a mouse model.
    Wolnicka-Glubisz A; Noonan FP
    Photochem Photobiol Sci; 2006 Feb; 5(2):254-60. PubMed ID: 16465311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma.
    Kanetsky PA; Holmes R; Walker A; Najarian D; Swoyer J; Guerry D; Halpern A; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):509-13. PubMed ID: 11352862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.
    Berneburg M; Clingen PH; Harcourt SA; Lowe JE; Taylor EM; Green MH; Krutmann J; Arlett CF; Lehmann AR
    Cancer Res; 2000 Jan; 60(2):431-8. PubMed ID: 10667598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ICAM-1 polymorphisms and development of cutaneous malignant melanoma.
    Howell WM; Rose-Zerilli MJ; Theaker JM; Bateman AC
    Int J Immunogenet; 2005 Dec; 32(6):367-73. PubMed ID: 16313300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xeroderma pigmentosum.
    Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
    Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of Barcelona.
    Puig S; Castro J; Ventura PJ; Ruiz A; Ascaso C; Malvehy J; Estivill X; Mascaro JM; Lecha M; Castel T
    Melanoma Res; 2000 Jun; 10(3):231-6. PubMed ID: 10890376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
    Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
    DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of XP-C pathogenic variations in archival material from a live XP patient.
    McDaniel LD; Rivera-Begeman A; Doughty AT; Schultz RA; Friedberg EC
    DNA Repair (Amst); 2007 Jan; 6(1):115-20. PubMed ID: 17084680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
    Clingen PH; Arlett CF; Hartley JA; Parris CN
    Exp Cell Res; 2007 Feb; 313(4):753-60. PubMed ID: 17188678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families.
    Hocevar M; Avbelj M; Perić B; Zgajnar J; Besić N; Battelino T
    Croat Med J; 2006 Dec; 47(6):851-4. PubMed ID: 17167857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.